pISSN 1226-6051
eISSN 2508-786X

Table. 4.

Table. 4.

Detected signal of DPP-IV inhibitors according to PT levels

SOC levels PT levels Reports of AEs (n) Crude ROR (95% CI)

AE AE Code DPP-IV inhibitor Other oral hypoglycemic agents
Skin and appendage disorders Pruritus 24 113 247 2.474 (1.968-3.111)
Rash 27 61 125 2.591 (1.899-3.536)
Urticaria 44 38 97 2.058 (1.409-3.005)
Bullous eruption/ Papulovesicular rash 30, 871 5 7 3.716 (1.178-11.722)

Musculo-skeletal system disorders Arthralgia 63 7 6 6.078 (2.040-18.107)

Respiratory system disorders Pharyngitis 523 28 2 73.900 (17.587-310.494)
Coughing 513 9 9 5.214 (2.067-13.154)

AE, adverse event; DPP-IV, dipeptidyl peptidase-IV; PT, Preferred Terms; ROR, reporting odds ratio; SOC, system organ class

Korean J Clin Pharm 2024;34:100-7 https://doi.org/10.24304/kjcp.2024.34.2.100
© 2024 Korean J Clin Pharm